CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 118.75M | 132.42M | 131.74M | 98.59M | 82.35M |
| Total Depreciation and Amortization | 70.67M | 70.46M | 70.15M | 70.05M | 70.28M |
| Total Amortization of Deferred Charges | 7.14M | 7.10M | 7.46M | 7.56M | 7.66M |
| Total Other Non-Cash Items | 10.32M | -3.29M | -19.16M | 8.30M | 15.07M |
| Change in Net Operating Assets | -27.50M | -39.72M | -10.16M | -9.55M | -17.04M |
| Cash from Operations | 179.38M | 166.97M | 180.03M | 174.95M | 158.32M |
| Capital Expenditure | -14.83M | -13.08M | -13.90M | -15.87M | -16.81M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 850.00K | -- | 0.00 | 0.00 | -1.00M |
| Cash from Investing | -13.98M | -13.08M | -13.90M | -15.87M | -17.81M |
| Total Debt Issued | 663.00M | 751.00M | 781.00M | 819.00M | 773.00M |
| Total Debt Repaid | -765.59M | -823.00M | -857.00M | -901.00M | -854.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -24.68M | -24.65M | -24.62M | -24.61M | -24.56M |
| Other Financing Activities | -35.12M | -54.35M | -58.07M | -50.49M | -27.24M |
| Cash from Financing | -162.38M | -151.00M | -158.70M | -157.09M | -132.80M |
| Foreign Exchange rate Adjustments | -1.39M | -2.72M | 535.00K | -960.00K | -346.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.63M | 163.00K | 7.97M | 1.02M | 7.36M |